| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Exelixis, Inc. (EXEL) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. EXEL is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.96M | $103.88M | - | |
| Dir | 1.55M | $82.12M | - | |
| Dir | 1.19M | $62.87M | - | |
| CFO | 1.12M | $59.07M | - | |
| VP | 594.7K | $31.44M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 25, 2019 | Schwab Gisela67 | Pres, Prod Dev &Med Aff &CMO | Sale+OE | 100,000 | $23.14 | $2,314,000.00 | -24.0% | |
| Mar 14, 2019 | Haley Patrick J.56 | Sr. Vice President, Commercial | Sale+OE | 2,000 | $25.00 | $50,000.00 | -2.2% | |
| Mar 14, 2019 | Scangos George A77 | Director | Sell | 5,000 | $25.00 | $125,000.00 | -0.4% | |
| Mar 13, 2019 | Morrissey Michael | President And CEO | Sale+OE | 40,000 | $24.64 | $985,485.52 | -16.1% | |
| Mar 11, 2019 | Haley Patrick J.56 | Sr. Vice President, Commercial | Sell | 959 | $23.13 | $22,181.67 | -1.1% | |
| Mar 1, 2019 | Scangos George A77 | Director | Sell | 40,000 | $22.66 | $906,400.00 | -2.9% | |
| Feb 27, 2019 | Morrissey Michael | President And CEO | Sale+OE | 40,000 | $22.69 | $907,600.00 | -30.8% | |
| Feb 25, 2019 | Haley Patrick J.56 | Sr. Vice President, Commercial | Sell | 4,272 | $22.27 | $95,137.44 | -4.5% | |
| Feb 25, 2019 | Cohen Charles | Director | Sale+OE | 5,271 | $22.18 | $116,910.78 | -20.1% | |
| Feb 22, 2019 | Marchesi Vincent T | Director | Sale+OE | 41,250 | $21.50 | $886,875.00 | -23.6% |